Physician profile
Michael T Dalley
NPI 1780623496
$2,427.17
in general payments reported to CMS, 2019-2025
9 companies · $304 in 2025
The $304 reported for 2025 was more than what 89% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $169 · 2021: $365 · 2022: $481 · 2023: $318 · 2024: $380 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $804.93 | 2021-2025 | Dalvance, Teflaro, Avycaz |
| Pfizer INC. | $505.36 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $295.55 | 2019-2024 | Xarelto |
| Allergan, INC. | $268.95 | 2019-2020 | |
| Csl Behring | $250.93 | 2019-2022 | |
| Gilead Sciences, INC. | $130.32 | 2023-2024 | Veklury |
| E.R. Squibb & Sons, L.L.C. | $76.09 | 2019-2024 | Eliquis |
| Astrazeneca Pharmaceuticals Lp | $70.59 | 2023-2024 | Lokelma, Farxiga |
| Biosense Webster, INC. | $24.45 | 2023 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dalley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.